Antibodies capable of binding to the spike protein of cononavirus sars-cov-2
AssigneeRqbio Covid Limited
InventorsJuthathip MONGKOLSAPAYA, Gavin SCREATON
Life of this patent
Estimating the term…
Abstract
The disclosure relates to antibodies useful for the prevention, treatment and/or diagnosis of coronavirus infections, and diseases and/or complications associated with coronavirus infections, including COVID-19. In particular, the disclosure relates to antibodies capable of binding to the spike protein of coronavirus SARS-CoV-2 and uses thereof.
Claims31
An antibody capable of binding to the spike protein of coronavirus SARS-CoV-2, wherein the antibody comprises at least three CDRs of antibody Omi12, or of any one of the 27 antibodies in Table 3.
The antibody of any one of the preceding claims, wherein the antibody in Tables 3 to 12 is selected from the group consisting of:
- (a) Omi02, Omi03, Omi12, Omi18, Omi28, Omi39 and Omi42;
- (b) Omi03 and Omi12;
- (c) Omi03, Omi12, Omi02, Omi39, and Omi42;
- (d) Omi03, Omi12, Omi02, Omi39, Omi42, Omi16, Omi18, Omi20, Omi23, Omi28 and Omi08;
- or
- (e) Omi03, Omi12, Omi02, Omi39, Omi42, Omi16, Omi18, Omi20, Omi 23, Omi28, Omi08, Omi17, Omi29, Omi36 and Omi38.
The antibody according to any one of the preceding claims, which is a full-length antibody, e.g. comprising a IgG1 constant region, or comprises an Fc region comprising at least one modification such that serum half-life is extended.
The antibody according to any one of the preceding claims, wherein the antibody is derived from germline heavy chain IGHV1-58, such as Omi-12, Beta-47, Beta-25, antibody 55, antibody 165, antibody 253, and antibody 318, and comprises proline at position 53 in the heavy chain variable region.
A combination of antibodies comprising two or more antibodies according to any one of the preceding claims.
The method according to claim 19 or 20, wherein the method is for treating SARS-CoV-2 infection, or a disease or complication associated therewith, such as COVID-19.
An antibody derived from germline heavy chain IGHV1-58, capable of binding to the spike protein of coronavirus SARS-CoV-2, wherein the amino acid at position 58 in the heavy chain variable region according to IMGT numbering is proline or is substituted with proline.
An antibody capable of binding to the spike protein of coronavirus SARS-CoV-2 comprising a heavy chain variable domain comprising an amino acid sequence having ≥60%, ≥70%, ≥80%, ≥90%, ≥95%, ≥96%, ≥97%, ≥98%, ≥99% or 100% sequence identity to SEQ ID NO:
- 961, with the proviso that the amino acid at position 58 according to IMGT numbering is proline or is substituted with proline.
Dependencies are inferred from the claim text.